vs
Genius Sports Ltd（GENI）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
Rollins, Inc.的季度营收约是Genius Sports Ltd的1.8倍（$906.4M vs $510.9M），Rollins, Inc.净利率更高（11.9% vs -12.3%，领先24.2%），Rollins, Inc.自由现金流更多（$111.2M vs $69.6M），过去两年Genius Sports Ltd的营收复合增速更高（129.2% vs 0.8%）
Genius Sports是一家体育数据与科技企业，为体育联盟、博彩机构及媒体公司提供数据管理、视频流媒体和赛事诚信服务，致力于帮助合作伙伴优化运营效率、丰富用户体验，保障体育赛事的公平透明与商业价值落地。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
GENI vs ROL — 直观对比
营收规模更大
ROL
是对方的1.8倍
$510.9M
净利率更高
ROL
高出24.2%
-12.3%
自由现金流更多
ROL
多$41.7M
$69.6M
两年增速更快
GENI
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $510.9M | $906.4M |
| 净利润 | $-63.0M | $107.8M |
| 毛利率 | 25.2% | — |
| 营业利润率 | -11.5% | 16.1% |
| 净利率 | -12.3% | 11.9% |
| 营收同比 | — | 10.2% |
| 净利润同比 | — | 2.5% |
| 每股收益（稀释后） | — | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GENIROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $510.9M | $912.9M | ||
| Q3 25 | $335.4M | $1.0B | ||
| Q2 25 | $215.2M | $999.5M | ||
| Q1 25 | $119.7M | $822.5M | ||
| Q4 24 | $413.0M | $832.2M | ||
| Q3 24 | $285.8M | $916.3M | ||
| Q2 24 | $184.1M | $891.9M |
净利润GENIROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $-63.0M | $116.4M | ||
| Q3 25 | — | $163.5M | ||
| Q2 25 | $-47.3M | $141.5M | ||
| Q1 25 | $-25.5M | $105.2M | ||
| Q4 24 | $-85.5M | $105.7M | ||
| Q3 24 | $-47.1M | $136.9M | ||
| Q2 24 | $-35.5M | $129.4M |
毛利率GENIROL
| Q1 26 | — | — | ||
| Q4 25 | 25.2% | — | ||
| Q3 25 | 24.2% | — | ||
| Q2 25 | 19.1% | — | ||
| Q1 25 | 10.7% | — | ||
| Q4 24 | 16.7% | — | ||
| Q3 24 | 20.5% | — | ||
| Q2 24 | 18.6% | — |
营业利润率GENIROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | -11.5% | 17.5% | ||
| Q3 25 | -15.3% | 21.9% | ||
| Q2 25 | -21.0% | 19.8% | ||
| Q1 25 | -20.3% | 17.3% | ||
| Q4 24 | -18.0% | 18.1% | ||
| Q3 24 | -13.9% | 20.9% | ||
| Q2 24 | -16.8% | 20.4% |
净利率GENIROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | -12.3% | 12.8% | ||
| Q3 25 | — | 15.9% | ||
| Q2 25 | -22.0% | 14.2% | ||
| Q1 25 | -21.3% | 12.8% | ||
| Q4 24 | -20.7% | 12.7% | ||
| Q3 24 | -16.5% | 14.9% | ||
| Q2 24 | -19.3% | 14.5% |
每股收益（稀释后）GENIROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.34 | ||
| Q2 25 | — | $0.29 | ||
| Q1 25 | — | $0.22 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $0.28 | ||
| Q2 24 | — | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $280.6M | $116.5M |
| 总债务越低越好 | — | $650.6M |
| 股东权益账面价值 | $724.5M | $1.4B |
| 总资产 | $1.1B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资GENIROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $280.6M | $100.0M | ||
| Q3 25 | $110.2M | $127.4M | ||
| Q2 25 | $110.2M | $123.0M | ||
| Q1 25 | $110.2M | $201.2M | ||
| Q4 24 | $100.3M | $89.6M | ||
| Q3 24 | $100.3M | $95.3M | ||
| Q2 24 | $100.3M | $106.7M |
总债务GENIROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | — | $486.1M | ||
| Q3 25 | — | $485.7M | ||
| Q2 25 | — | $485.3M | ||
| Q1 25 | — | $485.5M | ||
| Q4 24 | — | $395.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益GENIROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $724.5M | $1.4B | ||
| Q3 25 | $572.4M | $1.5B | ||
| Q2 25 | $572.4M | $1.4B | ||
| Q1 25 | $572.4M | $1.4B | ||
| Q4 24 | $573.0M | $1.3B | ||
| Q3 24 | $573.0M | $1.3B | ||
| Q2 24 | $573.0M | $1.2B |
总资产GENIROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $1.1B | $3.1B | ||
| Q3 25 | $792.3M | $3.2B | ||
| Q2 25 | $792.3M | $3.2B | ||
| Q1 25 | $792.3M | $2.9B | ||
| Q4 24 | $775.7M | $2.8B | ||
| Q3 24 | $775.7M | $2.8B | ||
| Q2 24 | $775.7M | $2.8B |
负债/权益比GENIROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.36× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $81.9M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $69.6M | $111.2M |
| 自由现金流率自由现金流/营收 | 13.6% | 12.3% |
| 资本支出强度资本支出/营收 | 2.4% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 1.10× |
| 过去12个月自由现金流最近4个季度 | $33.5M | $621.1M |
8季度趋势，按日历期对齐
经营现金流GENIROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $81.9M | $164.7M | ||
| Q3 25 | $-4.8M | $191.3M | ||
| Q2 25 | $-1.2M | $175.1M | ||
| Q1 25 | $-14.6M | $146.9M | ||
| Q4 24 | $14.9M | $188.2M | ||
| Q3 24 | $-9.2M | $146.9M | ||
| Q2 24 | — | $145.1M |
自由现金流GENIROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $69.6M | $159.0M | ||
| Q3 25 | $-14.2M | $182.8M | ||
| Q2 25 | $-5.8M | $168.0M | ||
| Q1 25 | $-16.0M | $140.1M | ||
| Q4 24 | $11.3M | $184.0M | ||
| Q3 24 | $-11.6M | $139.4M | ||
| Q2 24 | — | $136.4M |
自由现金流率GENIROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | 13.6% | 17.4% | ||
| Q3 25 | -4.2% | 17.8% | ||
| Q2 25 | -2.7% | 16.8% | ||
| Q1 25 | -13.4% | 17.0% | ||
| Q4 24 | 2.7% | 22.1% | ||
| Q3 24 | -4.1% | 15.2% | ||
| Q2 24 | — | 15.3% |
资本支出强度GENIROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 2.4% | 0.6% | ||
| Q3 25 | 2.8% | 0.8% | ||
| Q2 25 | 2.1% | 0.7% | ||
| Q1 25 | 1.2% | 0.8% | ||
| Q4 24 | 0.9% | 0.5% | ||
| Q3 24 | 0.9% | 0.8% | ||
| Q2 24 | — | 1.0% |
现金转化率GENIROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | — | 1.41× | ||
| Q3 25 | — | 1.17× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 1.40× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 1.07× | ||
| Q2 24 | — | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
